(Q33983287)

30 July 2017

1 reference

title

Managing obesity like any other chronic condition. Long-term therapy may reduce comorbidity as well (English)

1 reference

30 July 2017

0 references

M Agrawal

1

1 reference

30 July 2017

M Worzniak

series ordinal

2

1 reference

30 July 2017

L Diamond

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

30 July 2017

Postgraduate Medicine

1 reference

30 July 2017

108

1 reference

30 July 2017

1

1 reference

30 July 2017

75-6, 79-82

1 reference

What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.

30 July 2017

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.07.1158

Obesity, weight loss and prognosis in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.07.1158

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.07.1158

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.07.1158

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.07.1158

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.07.1158

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.07.1158

Appetite suppressants and primary pulmonary hypertension in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.07.1158

Primary pulmonary hypertension associated with the use of fenfluramine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.07.1158

Valvular heart disease associated with fenfluramine-phentermine

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.07.1158

Long-term weight control: the National Heart, Lung, and Blood Institute funded multimodal intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.07.1158

Comparison of continuous and intermittent anorectic therapy in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.07.1158

Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.07.1158

21 January 2018

Identifiers

DOI

10.3810/PGM.2000.07.1158

1 reference

30 July 2017

1 reference